COMING SOON: An actionable, easy-to-understand Muscle Assessment Score (MAsS)—generated by a rapid MRI scan and our precise body composition measurements—to help clinicians diagnose sarcopenia and make pre- and post-organ transplant decisions.
AMRA® MAsS Scan is awaiting CE-marking in Q2 2022.
After sending us MR images, we send you a patient-specific report where you’ll find AMRA’s Muscle Assessment Score (MAsS), anatomically accurate and precise body composition measurements with contextual insights based on our reference database.
Anatomic and color-coded images, which can help you and your patients see how and where changes are occuring.
AMRA® Profiler 4 is awaiting CE-mark approval in EU Q2 2022.
Send us a message and we will happily provide more information or a quotation.
When you partner with AMRA for your clinical MRI needs, you reap the benefits of our unrivalled digital health platform and normative database for body composition profiling—generated by our team of analysis engineers and body composition scientists.
Our MRI-based services are designed with you and your patients at the top of our priority list, and our vast experience in body composition analysis for metabolic diseases equips our team with the skills, knowledge, and passion required to develop the solutions you need.